In addition, ChIP-PCR showed that MEF2A could bind to the promoters of cardiac hypertrophy biomarker genes such as ANP, BNP, and β-MHC, suggesting its role in the transcriptional regulation of these genes (Fig 5C). This evidence concerns the gene NPPA and cardiac hypertrophy.